The company recently pivoted from a dormant investment and financial services entity into an active trader and manufacturer of agricultural commodities and products.
The company operates in a highly commoditized agricultural trading market with no evidence of cost advantages or brand power. Financial metrics show extremely low returns on capital (ROCE 4.7%) and negative cash conversion, contradicting any claim of a durable competitive advantage.
Historical capital was tied up in a partnership that was liquidated to fund a pivot into agri-trading. Recent activity involves a large preferential allotment and bonus issue that significantly diluted equity without yet proving sustainable high-return reinvestment.
The company's pivot into agricultural trading collapsed as the lack of a competitive advantage met the reality of razor-thin margins. The material uncertainties regarding trade receivables and unverified inventory, previously flagged by auditors, eventually crystallized into massive write-offs. Regulatory intervention by the RBI over the unregistered NBFC activity forced a fire sale of assets, while the frequent turnover of key personnel left no one to manage the fallout, resulting in a permanent impairment of capital for minority shareholders.
RichFakir rates Consecutive Commodities Limited's business quality as poor — 34/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Consecutive Commodities Limited is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Consecutive Commodities Limited is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Consecutive Commodities Limited's fair value is about ₹0 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →